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Abstract
Background: The answers to patient reported outcome measures and global transition questions for back pain can
be discordant. For example, the most commonly used outcome measure in back pain trials, the Roland Morris
Disability Questionnaire (RMDQ), can show improvement even though participants say that their back pain is worse.
This gives cause for concern as transition questions are used as anchors to estimate minimally important change (MIC)
thresholds on patient reported outcome measures such as the RMDQ. We aimed to explore and compare what
people with back pain think when they respond to a transition question and when they complete the RMDQ.
Methods: We purposively sampled people enrolled on a back pain randomised controlled trial who completed the
RMDQ and two transition questions. One enquired about change in ability to perform tasks, the other about change
in back pain. We sampled participants with discordance (in both directions), and participants with concordant scores.
We explored participants’ thought processes using in-depth interviews.
Results: We completed 35 in-depth interviews. People with discordant RMDQ change and transition question
responses attend to different factors when responding to transition questions compared to people with concordant
scores. In particular, those for whom the RMDQ change indicated greater improvement than transition questions,
prioritised their pain ahead of functional disability. When completing the RMDQ, participants’ thought processes were
comparatively more objective, and specific to each statement.
Conclusion: Approaches to primary outcome assessment in back pain needs re-assessment. The RMDQmay be
unsuitable for use as a primary outcome measure since patients may not attend to thinking about their back pain
when completing it: patients’ abilities to cope with tasks can be independent of the change in their back pain. Some
participants who improve on the RMDQ consider themselves globally worse. As transition questions can be driven by
pain and other physical factors, transition questions should not be used to anchor minimally important change
thresholds on the RMDQ.
Keywords: Low back pain, Outcome assessment, Measurement, Qualitative research, Roland morris disability
questionnaire, Global transition question, Inclusive thinking
Background
Low back pain (LBP) is a common and costly health com-
plaint; its life-time prevalence may be as high as 84%
[1]. Around 4% of the UK population take time off work
because of low back pain, which equates to around 90 mil-
lion working days lost and between eight and 12 million
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GP consultations per year [2,3]. Globally, LBP ranked
number one for contributions to Years Lived with Disabil-
ity (YLDs) in 2012 [4].
It is recommended that the performance of Patient
Reported Outcome Measures (PROMs) for measuring
health outcomes is carefully and systematically evalu-
ated prior to their use in clinical trials [5]. Steps of
this process can necessitate the use of a global transi-
tion question (TQ). A TQ is also a PROM but a special
case, as in contrast to most instruments that cover one
or more domains with multiple questions, TQs contain
only a single question asking if a patient has improved
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or deteriorated since beginning treatment [6]. TQs facili-
tate evaluation of responsiveness and minimal important
change (MIC) thresholds for PROMs, through being used
as ‘anchors’ – that is to say, the PROM scores of those
responding in a particular category of the TQ are cate-
gorised for analysis, and then used to dichotomise PROM
score improvements; in Receiver Operator Characteristic
(ROC) curves for example [7]. Well-performing PROMs
are selected for use as outcome measures in clinical tri-
als of treatments for chronic conditions, as well as for use
in clinical practice [5]. In clinical practice, management
decisions about individual patients can be based upon
clinical assessments/examinations, biometrics, clinimet-
rics, and/or psychometrics. However, when evaluating
changes in chronic conditions with variable courses (such
as low back pain), for which there are no reliable objective
tests, practitioners may simply ask patients whether or not
they are any better—essentially the same question posed
by a TQ. TQ responses have been shown to be discordant
with low back pain (LBP) PROM scores and one criticism
of TQs is that they may not always adequately measure
change even though that is what they are designed to do
[8,9].
Interventions for treating LBP are typically evaluated
and compared using pragmatic Randomised Controlled
Trials (RCTs), in which PROMs are typically used to eval-
uate participants’ health change and to explore between-
group differences in health changes. The Roland Morris
Disability Questionnaire (RMDQ) is the most commonly
cited primary outcome measure in LBP trials [10]. In one
of the largest trials of a physical therapy for LBP, par-
ticipants’ RMDQ scores indicated an improvement on
average, even in those participants who said that their
back pain was worse [8]. In order to further assess whether
it is appropriate to use the TQ to make inferences about
the RMDQ (and vice versa), we used in-depth interviews
to explore what people with back pain think about when
they complete the RMDQ andwhen they respond to a TQ.
Methods
In this study, participants were recruited from a sample
of participants in a pilot cluster RCT (ISRCTN46035546)
of informed shared decision-making. Participants, who
were recruited to the trial from a National Health Ser-
vice (NHS) physiotherapy department in Coventry UK,
were aged 18 or over and due to receive physical ther-
apy as a treatment for their non-specific LBP [11]. All
participants needed to be fluent in English. The trial pro-
tocol and results are described in full detail elsewhere.
Participants were informed by a trial participant informa-
tion sheet that once they had returned their four-month
follow-up questionnaire they may be approached to take
part in a related interview study looking at how changes
in back pain are measured and that further participation
in this study would be voluntary [11,12]. We contacted
participants by post, including a participant information
sheet for the interview study and a form on which to reg-
ister their interest. We obtained written informed consent
at the time of the interview, directly from participants.
After the interview, participants were given £20 (GBP) of
high-street vouchers to thank them for their time. The
study protocol received ethics approval from the National
Research Ethics Service (NRES) Committee South East
Coast – Brighton and Sussex Research Ethics Committee
(REC) (11/LO/1190).
Participants in the trial had completed the original
(1982) version of the RMDQ and TQs at baseline and at
four months [6,13]. To explore the effect of TQ wording
in this trial sub-study, at the design-stage of the trial we
included two different TQs. One TQ asked ‘Since begin-
ning treatment how would you describe the change in
your low back pain?’ and the other asked ‘Since begin-
ning treatment how would you describe the change in
your ability to perform daily tasks?’ Each TQ utilised the
same 7-point response options, where anchors ranged
from 1=Completely better, to 7=Vastly worse (Footnote to
Table 1).
Informed by the baseline and four-month follow-up
data, we purposively sampled participants by gender, age,
employment status, and ‘discordance status’. We aimed
to sample between 35 and 40 participants, within which
range we expected to be approaching data saturation. We
purposively sampled one participant who had missing TQ
data, in order to explore the reason for non-response.
We categorised discordance status both by its presence
or absence, and by its direction. We defined discordance,
a priori, as either a change on the RMDQ of any mag-
nitude in a contradictory direction with respect to any
TQ response that was not ‘no change’, or where there was
a ≥ 5-point change in RMDQ score in the same direc-
tion when the response to the TQ was slightly improved
(i.e. - status) or slightly worse (i.e. + status), or where
there was a <= 5 point change it the TQ response was
‘much improved’, unless the follow-up score was zero and
thus prevented from exceeding the threshold by a floor
effect. There is some consensus that a 5-point change
on the RMDQ is an appropriate threshold to judge an
individual responder [14]. We then coded cases of posi-
tive discordance (+) as when the TQ response indicated
a more optimistic view of recovery than the correspond-
ing change in RMDQ score, and negative discordance (-)
when the TQ presented a more negative response than
the RMDQ score. Concordance (i.e the absence of discor-
dance, where the response to the TQ was consistent with
the RMDQ) was coded as ‘0’. Since there were two tran-
sition questions we use two characters for notation. The
first corresponds to the LBP TQ, which participants were











Table 1 Transition question responses
ID Age Ethnicity Gender Employment Leg pain RMDQ RMDQ RMDQ TQ LBP TQ Discordance
baseline follow-up change daily tasks
1 63 White British Female Retired No 15 12 -3 4 4 – –
2 70 White British Female Retired Yes 11 13 2 3 3 ++
3 57 White British Female Full Time No 17 16 -1 3 3 00
4 61 White British Female Part Time No 14 2 -12 3 3 – –
5 45 White British Female Full Time Yes 10 4 -6 3 3 – –
6 47 White British Female Part Time No 11 7 -4 3 4 0-
7 23 Asian British∗ Female Full Time Yes 11 12 1 4 4 00
8 74 White British Female Retired No 12 11 -1 3 3 00
9 49 Asian British∗ Female Full Time No 18 8 -10 3 2 -0
10 57 White British Female Part Time Yes 12 10 -2 3 3 00
11 58 White British Female Unassigned No 12 10 -2 3 3 00
12 64 White British Female Unassigned Yes 18 6 -12 3 2 -0
13 58 White British Male Not working Yes 19 19 0 ND ND ND
14 54 White British Male Full Time No 6 2 -4 2 2 ++
15 55 White British Male Retired Yes 14 0 -14 2 2 00
16 67 White British Female Retired Yes 8 7 -1 3 2 0+
17 57 White British Female Full Time Yes 7 16 9 7 7 00
18 56 White British Female Part Time Yes 11 4 -7 2 2 00
19 73 White British Female Retired No 10 10 0 4 4 00
20 64 White British Female Retired Yes 15 16 1 4 4 ++
21 65 White British Female Retired Yes 4 2 -2 4 4 – –
22 34 White British Female Not working No 4 0 -4 2 2 00
23 37 Asian Male Not working Yes 17 17 0 6 5 – –
24 65 White Cypriot Male Part Time No 14 11 -3 3 3 00
25 42 White British Male Full Time No 2 0 -2 2 7 +-
26 20 White British Male Not working No 14 19 5 7 6 00
27 48 White British Female Not working No 7 8 1 3 3 ++
28 40 White British Female Full Time No 7 0 -7 2 2 00
29 48 White British Female Part Time No 12 10 -2 4 4 – –
30 59 White British Female Not working Yes 19 20 1 4 4 00
31 74 White British Female Retired No 12 14 2 4 4 ++
32 45 Black British† Female Unassigned Yes 12 10 -2 3 3 00
33 63 White British Female Retired No 6 4 -2 3 4 00
34 64 White British Female Retired No 11 9 -2 5 5 – –
35 31 Mixed‡ Male Full Time Yes 14 6 -8 2 2 00
Concordance rule details: No change = within 1 points of 0; Slightly< 5 points in concordant direction (i.e> 0); Much>= 5 points in concordant direction; Character 1 = LBP, Character 2 = tasks; - = TQ less optimistic than
RMDQ change score; + = TQmore optimistic than RMDQ change score; ND = No Data/datum. For example, a participant with a discordance status of ++ indicates a more optimistic response to both transition questions
relative to the RMDQ change score. A participant with status 0- would be concordant with respect to the TQ that is worded in terms of LBP, but would have a less optimistic daily task TQ as compared to the RMDQ change score.
TQ anchors 1=Completely better; 2=Much better; 3=Slightly better; 4=No change, 5=Slightly worse, 6=Much worse; 7=Vastly worse.
∗Asian or Asian British Indian.
†Black or Black British African.
‡White and Afro-American.
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TQ, which participants were asked second. We did not
explore in the study the effect of changing the order of the
transition questions.
We aimed to interview participants within four-weeks
of receiving their four-month follow-up data, to minimise
difficulty with recall. Interviews were semi-structured and
performed either at the participant’s home, or at Warwick
Medical School; whichever the participant preferred. Dur-
ing each one-hour interview, in accordance with a topic
guide [see Additional file 1] participants were invited to
describe their back pain and its impact, before being asked
to review their responses to the RMDQ and TQs, and to
describe their thought patterns and approach to answer-
ing the questions. If discordance was present, the reasons
for it were explored.
All interviews were audio recorded and transcribed ver-
batim. NVivo, version 10 (QSR International, Queensland,
Australia) was used to store the transcripts and facilitate
data management. Coding was undertaken by DE with
RF providing independent quality checks on 20% of tran-
scripts early in the coding process. Of these, half were
randomly selected and half were purposively selected by
DE as those that were judged as most difficult to code.
We adopted a thematic approach for analysis, coding
according to a framework that was developed from ini-
tial readings of the transcripts to model data relating to
thoughts and thought processes and we examined these
relative to discordance between the RMDQ change score
and the TQs [15]. Additional codes were added as themes
emerged from the data. DE and RF developed the initial
framework from coding several transcripts. Coding dis-
crepancies were discussed and coding definitions refined.
DE, RF, SP, and MU discussed the final framework and
its themes and definitions, and in a research meeting the
framework coding was compared to individual transcripts
for triangulation. We focused on exploring themes that
emerged when the participants were questioned about
how they came to a decision to answer the RMDQ or
TQs. We then examined these themes as a function of
the participant’s coded discordance status (vide ibid). We
explored associations by comparing data coded under dif-
ferent themes with characteristics and other factors. For
example, associations between discordance status cod-
ing and different coded categories of interview responses
were explored by forming matrices and exploring data
within and between cases. Quotations were presented as
exemplars of themes. Each presented quote is coded using
the following syntax: [ID number, gender (m/f), age in
years, discordance status (e.g. ++, – –, -0)].
Results
We completed 35 interviews before approaching data sat-
uration. Table 1 summarises the characteristics of the
sample as well as the participants’ responses to the TQs
and their RMDQ scores. Twenty-seven participants were
female (mean age 56 (SD 12.39) years) and eight were
male (mean age 45 (SD 15.32 years). Most were British
(29/35). Nine worked full-time, six worked part-time, 11
were retired, six were not working, and three did not
provide their work status. Within the purposive sample,
the mean RMDQ at baseline was 11.6 (SD=4.39) and the
four-month follow-up it was 9.0 (SD=5.89).
All participants had responded to the RMDQ at base-
line. The participant with missing TQ data had simply not
seen the page containing these questions. At follow-up, 15
participants were discordant with the LBPTQ and 15were
discordant with the daily tasks TQ. Twelve were discor-
dant on both questions. In five, the TQs suggested better
outcomes than the RMDQ change scores (++) and in
seven it suggested worse outcomes than the RMDQ (– –).
Of the heterogeneously discordant responses, two were
discordant with the pain question but not the tasks, two
were discordant with tasks but not pain, and one was dis-
cordant with both but in opposite directions. Seventeen
participants were not discordant with either TQ.
Roland Morris disability questionnaire
We identified two themes in terms of participants’
thought patterns that were associated with completion of
the RMDQ.
Binary opposition thought-process
Participants’ thought-processes follow directly from the
structure of the questionnaire. Participants tended to take
a uniform approach involving attending to each of the
RMDQ statements in turn, as they are presented, and con-
sidering each relatively objectively and dichotomously in
terms of assessing whether the statement was true or not,
as required by the questionnaire. For example, if a par-
ticipant was considering the statement ‘I need to use a
handrail when climbing the stairs because of my back’, this
was something that they judged that either they needed to
do, or that they did not need to do; i.e. a binary opposition.
The statements did not in general lead to debate, difficulty,
or dilemma, but directly to a decision and concluding
statement of agreement or disagreement. No associations
emerged between gender, age, employment status, or dis-
cordance status.
“That one I do [change positions frequently because of
back pain], you know, if I’m sitting on the sofa watching
the TV, I tend to move and then move to the other side
and, you know, put my feet up. I do still do that.” -
(Participant 2, 70 yo White British Female, ++)
“No, I don’t stay at home most of the time. Do I change
positions frequently? No. Walk more slowly? Don’t think
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so. Not doing jobs I usually do around the house? I have
to take some care cleaning the bath, but it’s only that. ...
Handrail? No. ” - (Participant 12, 64 yo White British
Female, -0)
Temporal irrelevance
We identified the second theme from several participants
who commented that the RMDQwording asks about abil-
ity ‘today’. Participants felt this risked responses being
over-influenced by an atypically ‘good’, or an atypically
‘bad’ day, and thus the RMDQ failed to capture relevant
information about symptoms over time.
“On this day is it bad, you know? ... But if it’s on a good
day, then it’s OK, but like I know mine obviously did go
really quite high then ... that particular week, I’d been
sitting a lot because I’d been out for meals, as I say and
sort of down to K*** as well, which made my problem
worse then in that week. ... possibly within [the RMDQ
should inquire about] the last month, because that’s the
thing, it isn’t always just that day, is it? It depends on
what’s made it worse today than last week sort of thing.”
- (Participant 21, 65 yo White British Female, – –)
“ ... it does say today, doesn’t it? ... I was taking it more
as a general ... I mean, today is underlined as well. ...
there are things ... like this one, I could say I’ve done this
more as a general one and that one more as, er .. how I
was on that day.” - (Participant 24, 65 yo White Cypriot
Male, 00)
“... it would be good if you did something like every
couple of days; instead of just doing it the once, to do it
over a week period or something? ... Because sometimes
you can be really good and you fill it in and you think,
oh, yeah, I can do that, I can do that! But then the next
day, I couldn’t!” - (Participant 28, 40 yo White British
Female, 00)
Health transition question (TQ)
Five distinctive thought pathways emerged as themes in
the data that related to thought processes during par-
ticipants’ responses to TQs; particularly in terms of the
prioritising and order of consideration of health domains
(Figure 1). Participants either thought about pain then
function; function then pain; their willingness to glob-
ally accept their health state globally; pain alone; or
pain and then fear. The pathways are listed in order
of the prevalence expressed within our purposive sam-
ple. Notwithstanding the differing categories and chrono-
logical orders of thought processes observed, we note
that generally thoughts about the pain were at the fore-
front of thought processes. The thought process for some
was simple and generally required little mental debate;
however, most made a more considered appraisal. This
Figure 1 Decision-makingpathways. The figure shows the five emerging themes in descriptions of thought pathways, and the association with
discordance status. D=discordant; ND=not discordant.
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framework accommodates all of the qualitative data relat-
ing to thoughts and thought pathways.
The following sections summarise each of the thought
pathways identified within the framework. They include
relevant example quotes that were typical of responses,
and describe any discordances observed and their
directions.
Participants who thought about their pain and then their
function
Of the 12 participants who thought about pain first and
then function [ID= 1, 8, 9, 16, 19, 22, 23, 25, 29, 31,
33, 34], eight had discordant RMDQ and TQ scores. Of
these, seven had less optimistic responses (i.e. were neg-
atively discordant) on either LBP or daily task variants of
the TQ and four had less optimistic responses on both
(i.e four had a discordance value of – –). These four
responses may be qualitatively different in that these par-
ticipants expressed more negatively emotional responses
than those who were classified as being positively discor-
dant and who expressed more optimism. Thoughts about
function tended to be centred around what participants
could or could not do (e.g. in terms of work or leisure).
“Yeah, because if the pain is there you can’t do things,
can you?” - (Participant 19, 73 yo White British
Female, 00)
“I think how much does it hurt, I suppose ... Yeah. As I
say, if we walk for a long distance, that definitely starts
aching.” - (Participant 8, 74 yoWhite British Female, 00)
“...But I think, yeah, the pain, the level of pain, the
intensity, is what determines everything else in your life;
whether it’s getting out of a chair, whether you need help
getting dressed. I mean, there were occasions when I did
need help to get dressed and so, therefore, if you say
what is it that makes you feel better, it is in some way
either lessening or losing the pain, because obviously
that makes life easy then.” - (Participant 1, 61 yo White
British F, – –)
“Well, yeah, you see, when I’m sitting like this, I can feel
a bit of tenderness sort of thing and I suppose it’s until
you come to walk, and you think, well, say, tomorrow I
might have a bit of pain, but I don’t have the pain every
day. And this is probably where you think, you think it’s
going but it never goes.” - (Participant 31, 74 yo White
British F, ++)
Participants who thought first about function
Of the eight participants who thought first about function
[ID= 5, 6, 11, 17, 18, 28, 32, 35], six were not discordant
(i.e. had a discordance value of 00) and two were discor-
dant. Of those who were discordant, there was no notable
directional association.
“ I could actually fit more into the day ... Housework
was easier ... The washing up would normally take you
five minutes, but it took, say, half an hour, so it was the
time thing of getting things done, you could do more.
Basic things like shopping was easier.” - (Participant 18,
56 yo White British Female, 00)
“It would be [better] from the first time that it
happened, you know, about getting in the car and, you
know, sitting for long periods. Because sometimes I do
have to sit at the computer for quite a while and
whatever, and I would say it was slightly better now,
because I can sit longer and I can do a little bit more;
whereas before when it first happened, I would say no”. -
(Participant 5, 45 yo White British Female, – –)
“... How far I can walk ... How long I can stand for; those
kind of things.” - (Participant 32, 45 yo Black or Black
British African Female, 00)
Participants who used inclusive thinking
Seven participants thought about their response in
relatively more global or complex terms [ID=2, 3, 4, 14,
15, 24, 27]. Three were concordant and four were
discordant, with three having more optimistic responses
to the TQ than indicated by the RMDQ change score (i.e.
were positively discordant) and one had less optimistic
TQ responses than indicated by the RMDQ change score
(i.e. were negatively discordant) for both variants of the
TQ. In this category, thinking was principally a global
appraisal, for example, incorporating multiple factors and
possibly interactions between those factors, or an
overview of a situation, rather than immediately thinking
of pain or another discrete factor. We have labelled this
‘inclusive thinking’. Responses reflect an adjustment or an
additional consideration that is incorporated in the
response to the TQ that is independent from responses to
the RMDQ. There may have been some suggestion that
those who were positively discordant had exceeded their
global expectations.
“...But, you know, at the end of the day, I have to accept
that I’m older now and there’s general wear and tear in
my body; to me there’s no doubt about that. So I don’t
think I’m ever going to get back to how I was ten years
ago, and I think this is something I’m going to have to
live with, you know? So is my ability slightly better?” -
(Participant 2, 70 yo White British Female, ++)
“I put that because when I’m not at work and I’m not
under pressure at work, I feel slightly better because I
can take my time doing the normal daily things that, if
you’re in a work pattern, that you would do
automatically.” - (Participant 3, 57 yo White British
Female 00)
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“Well, I don’t personally think I’ll ever be ever without
back pain. There will be days and weeks that I’ll have it,
so it’s never going to be ... it could maybe reach much
better, but it will never be completely better; you’ll never
get to that, only much better.” - (Participant 4,61 yo
White British F, – –)
“There’s a lot of residual effect of back pain that it does
restrict the things that you do; although I try not to let it
restrict the things that I want to do. Up until last year,
we were skiing every year and it didn’t stop me skiing. I
found the more exercise I did, good exercise, the better
off my back was, because I became fitter and my back
was stronger because of it ... ” - (Participant 14, 54 yo
White British Male ++)
“You know you’ve still got it there, you know it’s still not
100% and for my case, it will never be 100%, but you
just know that if you do what you should do and how
you go about it, you’ll be fine.” - (Participant 15, 55 yo
White British Male 00)
“In my head I felt slightly better. That may have been a
day when I was feeling a little bit more positive; even
though I was in pain, maybe part of me was thinking,
oh, this could be something, it could get better.” -
(Participant 27, 48 yo White British Female , + +)
Participants who thought only about their pain
Of the five participants who thought only about pain
when responding to the TQ [ID=7, 10, 20, 21, 26], two
were discordant and three were not discordant. One had
more optimistic responses to the TQ than indicated by
the RMDQ change score (i.e. was positively discordant)
for both LBP and daily task variants, and one had less
optimistic responses to the TQ than indicated by the
RMDQ change score (i.e. was negatively discordant) for
both variants.
There was some suggestion that for the participants in
this pathway the decision-making process was more clear-
cut and without lengthy mental debate. There were no
notable associations with discordance in either direction.
“My pain. Has anything changed? No, it’s still the same.
My pain is still the same. It’s simple!” - (Participant 7, 23
yo Asian or Asian British Female, 00)
“I think I thought am I in more pain now than I was when
I started? ... I think that’s what I’ve based it on, whether
my pain was any better or worse from start to finish and it
gradually got worse.” - (Participant 10, 57 yoWhite British
Female 00)
“Yeah ... well, no, just the pain, when I’m just having it
bad ... Yeah, this is just about the pain. If I was to say with
the mental stuff and not being able to do anything, then
it would be that one that’s really worse.” - (Participant 26,
20yo White British Male, 00)
“Well, because I still have back pain.” - (Participant 21,
65 yo White British Female, – –)
Participants who thought about their pain and then fear
Finally, of the two participants who thought about pain
and then fear [ID=12, 30] (that is, in terms of being wor-
ried about doing further damage to their back), one was
concordant and one had less optimistic TQ responses
than indicated by the RMDQ change score (i.e. was nega-
tively discordant) on only the LBP TQ (i.e. a discordance
value of –0)
“ ... it’s obviously not going to be there 24/7, it’s going
to ease off. But when you’re getting it, you don’t think it’s
going to ease off; you think, oh, and you get this fear that
something is going to happen to you, I keep thinking ... kept
thinking, will I end up on a stretcher and end up where I’m
paralysed, because it’s been so extreme!” - (Participant 30,
59 yo White British Female 00)
“When I say clicking, it doesn’t nearly describe it. You’d
be walking along normally, normally, normally, and then
suddenly, quiet unpredictably, get this really sharp pain as
though something is going to break! ... Yeah, because what
(this) was worrying me, frightening me and sent me to the
doctor ... was, oh, I’m doing some damage by walking; if
I carry on with this, I’m not going to be able to walk!” -
(Patient 12, 64 yo White British Female, -0)
Summary of discordance patterns within the framework
There were more participants who thought about pain
and then function than in any other of the five categories.
They were more likely to have RMDQ scores that were
discordant with TQ scores and the majority had higher
RMDQ change scores. In those who thought about pain
only, TQ responses largely matched RMDQ responses.
In the inclusive thinking category, there is some indica-
tion that those who had more optimistic TQ scores than
indicated by lower RMDQ change score had in some
way exceeded their own a priori expectations for their
improvement.
Discussion
The results of this study show how it is possible that
patients can say they have improved or deteriorated
whilst having a contradictory RMDQ change score: for
some patients the assessments are in different domains.
Ability to perform daily tasks (i.e. the domain of the
RMDQ) can be independent of back pain. Whilst par-
ticipants who thought principally about their function
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when answering TQs tended to have concordant TQ and
RMDQ responses, consideration of pain before function,
the predominant pathway, was associated with having a
less optimistic TQ response than RMDQ score, suggest-
ing that pain is the primary driver of the response to the
daily tasks TQ as well as for the LBP TQ.
This finding is problematic since it suggests that some
people do not attend to thinking about their back pain
when completing the RMDQ. This may render the RMDQ
unsuitable for use as a primary outcome measure in
back pain trials if the objective is to determine individual
change, or between-group differences in back pain. If the
focus were on improving daily living, it may provide useful
and relevant information.
In 2014, the National Institutes of Health (NIH) task
force recommended using Patient Reported Outcomes
Measurement Information System (PROMIS) measures
as a minimum dataset in all NIH-funded LBP research,
recommending that the RMDQ could be a substitution
for the PROMIS physical activity items if more extensive
legacy measures are required [16]. The RMDQ may be
well-placed for specifically measuring function. Notwith-
standing our findings, we note that the RMDQ usually
shows to be the superior instrument, strictly in terms of its
clinimetric performance when compared to other back-
specific measurement instruments; it has convincingly
been shown to be reliable and responsive [6,10,17-19].
Hush et al. have highlighted that participants have
expressed concern that the RMDQ had not seemed rel-
evant to them and that the time-frame of assessment of
the RMDQ was thought to be problematic [20]. Our find-
ings also suggest that some participants have concerns
surrounding relevance. It was felt that specific weaknesses
of the RMDQ included its focus on the day of completion
and its failure to measure recent recollection of ability,
confirming the original report of this issue. From a clinical
standpoint this could be considered a relative weakness
over measures that have a temporal component because
the trajectory of back pain from day-to-day is known to be
erratic [3].
Hush et al., in 2012, reviewed patients’ views on recov-
ery from low back pain [21]. This, combined with a
review of recovery measurement over the past decade,
[22] informed a workshop in which expert opinion was
sought on standardised recovery measures using the
nominal group method. For measuring recovery, they rec-
ommended the Global Back Pain Recovery Scale – a
transition question worded in terms of recovery – and the
Patient Generated Index (PGI) of Life-Back Pain [23,24].
Arguably a distinction should be made between recov-
ery measures and outcome measures. Kamper et al. note
the absence of a definition of recovery, which we suggest
inherently relates to the individual patient [22]. Mea-
surement of recovery and the analysis of the number of
recoveries in trials is emphatically useful, since it facil-
itates interpretation of trial outcomes [25,26]. Outcome
measurement should be considered more general; inas-
much as it charts the change in a latent variable, on
aggregate, regardless of whether recoveries (or deterio-
rations) have occurred in individual patients [27]. The
minimally important between-group (population-level)
difference of course usually forms the basis of the sample
size calculation for trials, and since magnitudes of impor-
tance at the population-level can differ from those at the
individual level, it is important to separate the level of
interest [28].
In a systematic review, in 2014, of qualitative research
on the impact of back pain on patients’ lives, Froud
et al. highlighted a discord with domain coverage of out-
come measures recommended in core sets [29]. As the
Patient Generated Index (PGI) permits participants to
define what matters most to them and then rate the
change in those domains, its use would improve the rele-
vance of outcome measurement in trials generally as well
as for measuring recovery in individuals [21,22]. How-
ever, there may be an inherent clinimetric weaknesses in
the current design of the PGI. Participants are asked to
both weight and rank their nominated domains of mea-
surement. This adds an additional source of variance,
which can disadvantage its metric performance relative to
other instruments. For example, when exploring reliabil-
ity, the increased within-person variance term is bound
to (reasonably assuming it to be greater than zero) atten-
uate the coefficient that is often used to summarise the
instrument’s reliability/agreement, [30,31] and could ren-
der the PGI less attractive from a clinimetric perspective,
relative to other available instruments. We would encour-
age clinimetric comparisons of variations on PGI designs;
for example, by removing the weighting, or permitting a
rating only at baseline.
The validity of using TQs in general has been ques-
tioned. Guyatt et al. [9] suggest that correlations of less
than 0.5 between the change in PROM score and TQ
should be grounds for doubting the construct validity of
the TQ. Indeed, criticisms of using TQs centre on the
rating’s likelihood to be more correlated with the follow-
up health state and PROM score, than baseline state and
PROM score, essentially highlighting that respondents
may not correctly recall their baseline health state. The
criticism may underline another more fundamental ques-
tion surrounding how interested we should be in the abil-
ity of the TQ to measure change. Guyatt also points out
that if the TQ measured change rather than being driven
by current health state, then one would expect to find a
correlation between baseline PROM score and the TQ,
and follow-up PROM score and the TQ that is present,
equal, and opposite [9]. In addition, in a linear regres-
sion model the follow-up PROM score should explain a
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significant and material proportion of the variance in the
TQ, which is often not the case [8,9,32]. However, we
consider that PROM scores are most useful in pragmatic
clinical trials, where establishing the effectiveness rather
than the efficacy of an intervention is the primary objec-
tive [33]. In pragmatic trials the focus on the follow-up
health state is sensible since pragmatic trials are chiefly
done to inform policy and in the case of back pain where
we are concerned with morbidity, rather than mortality,
the objective and post-treatment view of the patient is
more valuable to decision-making and directing health
spends. We agree with Ostelo et al. that most physicians
would be reluctant to label a patient as improved or deteri-
orated against that patient’s personal assessment [34]. We
support the recommendation of Hush et al. of using the
TQ to determine when recovery has occurred, and suggest
that it might also be useful as an outcome measure when
the focus is on health transition at the population-level.
Hush et al. [21] recommend using an 11-point outcome
measure based on a review by Kamper et al. and Preston
and Coleman’s work on optimal category scales, in 2000
[23,35].
Lauridsen et al., in 2007, compared a 7-point TQ with
a 15-point TQ for use as an external criterion for esti-
mating MIC on PROM instruments, within a group of
181 low back or leg pain patients receiving best care
who had completed five validated PROMs [36]. They also
examined different stringencies. They observed no dis-
criminatory difference, but as the 7-point scale produced
a slightly more conservative estimate they recommended
the 7-point scale for use as an external criterion.
Whilst potentially useful as an outcome measure at
population-level, as well as to measure recovery at the
individual-level, we would caution against using a TQ as
an external criterion to estimate RMDQ MIC thresholds
on ROC curves [37]. To be suitable for this purpose, the
TQ would need to a useful proxy measure of change,
and an accurate proxy measure of change within the
same domain as the RMDQ. On both counts the TQ is
inadequate; correlations and regression modelling from
other studies show that the TQ does not measure change,
[8,9,32] and the current study suggests that regardless of
TQ wording, it is pain that drives the transition question
and that this is independent of the domain measured by
the RMDQ.
We noted that we stopped the research when we
were approaching data saturation. We prefer the term
‘approaching data saturation’ over ‘data saturation’, which
we suggest may be a slightly unfortunate term. Whilst
often used to describe the point when no novel themes are
emerging, it may be an unrealistic or inaccurate descrip-
tor in that it is actually only the incidence of novel themes
decreases with data acquisition. Diminishing returns and
practicalities mean that when data saturation is being
approached it is reasonable to stop the research. With
a larger sample, we may have been able to obtain more
novel data. However, after 35 interviews in our study novel
themes were diminishing, and the willing and eligible per-
sons remaining had characteristics that had already been
well-sampled; as such we recognise a limitation. However,
it is a limitation that we suggest applies to most qualita-
tive research. The completion of 35 interviews exceeds the
size of many qualitative studies yet the sample was not so
large as to limit our capacity to analyse data [38]. Results
of qualitative research should not be considered gener-
alisable, due to purposive sampling, and in contrast to
representative sampling required for inference; however,
our results are transferable, insofar as they should reflect
the range of themes from the population.
Our results give cause for concern surrounding the use
of the most common primary outcome measure in back
pain trials; the RMDQ [10,39].We have supported sugges-
tions for exploring the use of the TQ and PGI as a primary
outcome measure, for their relevance to patients. How-
ever, we would not seek to discourage the development
of new instruments, especially those which exploit mod-
ern developmental approaches, and involve patients in the
development. One hazard in reconsidering primary out-
come measure use in LBP trials, could be that lessening
RMDQ use may pave the way for a more heterogeneous
usage of outcome measures; the very scenario that the
influential recommendations for core-sets in 1998 and
2000 was originally intended to correct [40,41]. Kamper
et al. have shown that between 1999 and 2008 measure-
ment of recovery has been diverse utilising a vast array
of different instruments and approaches [22]. We are cur-
rently exploring trends in outcome measurement, and
measurement heterogeneity, in back pain trials over the
past three decades (Froud R, et al. A systematic review
of outcome measure use and reporting methods in low
back pain trial reports published between 1980 and 2011.
In preparation.). Notwithstanding the risk of increasing
heterogeneity, the current situation in which the most
commonly used assessment method in trials and practice
does not correspond well to perceived changes in back
pain, is undesirable. One reason for heterogeneity may be
the absence of a compelling primary outcome measure,
making the argument for not developing new instruments
on the grounds of increasing heterogeneity difficult to
uphold. Given the huge costs and burden of back pain
on society, it could be viewed as regrettable (possibly
even unethical) that many millions are spent each year on
assessing health technologies for the improvement of back
pain, when one of the most commonly used back pain out-
come measures may not be capturing what is relevant to
patients.
At the design stage of any new instrument, we sug-
gest that researchers might consider whether there are
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any potentially useful viewpoints that have hitherto
been neglected, for example, by including linguists,
psychologists, psycho/clinimetricians and sociologists in
addition to patients and clinicians. We support ongoing
work aimed at reconsideration of these core sets, with
groups aligned with the Core Outcome Measures for
Effectiveness Trials (COMET) initiative, but emphasise
the importance of evaluating the design and clinimetric
performance before recommending the inclusion of an
instrument in core-sets. In assessing design and perfor-
mance of instruments, the COnsensus-based Standards
for the selection of health Measurement INstruments
(COSMIN) check-list may be useful. The aim of the
COSMIN initiative is to improve the selection of health
measurement instruments (www.cosmin.nl). Following a
Delphi study, the group developed a critical appraisal tool
and standards for evaluating the methodological qual-
ity of studies on the measurement properties of health
measurement instruments.
If new candidate(s) are selected as a preferred primary
outcome measure for use in low back pain trials, a smooth
transition may need to be managed. With the life of a
clinical trial spanning upwards of five-years from con-
ception to publication, some degree of fragmentation in
primary outcome measure use may be unavoidable and
should be considered as it would need to be clear whether
or not there would be sufficient buy-in from trialists to
minimise fragmentation. The Delphi method with a large
panel of trialists may be useful in this regard to see before-
hand whether consensus on change can be achieved; it
is not clear that recommendations on outcome measure-
ment and core sets are having any impact on altering
practice ([39], Froud R, et al. A systematic review of out-
come measure use and reporting methods in low back
pain trial reports published between 1980 and 2011. In
preparation). There may also be a detrimental effect to
comparisons between trials; although additionally stan-
dard effect sizes and responder analyses would go a long
way to mitigate this [16,25].
Conclusions
Approaches to primary outcome assessment in back
pain needs re-assessment. People do not think about
their back pain when they complete the most commonly
used primary outcome in back pain trials–the RMDQ.
Researching a more relevant substitute instrument for
use as a primary outcome measure in back pain trials
needs further consideration as do transition strategies
and ways to improve trialist buy-in. TQs should not be
used to anchor RMDQ MIC thresholds as these may
not provide a valid proxy of change in the latent con-
struct measured by the RMDQ but are primarily driven
by pain.
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